Dawonsys

068240 · KOSDAQ · ₩068240 · 다원시스

₩2,530 ₩0 (0.00%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

What brokers say about Dawonsys

No public broker reports on this company yet.

Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.

AI summary of public information

An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.

Dawonsys reports deep losses and heavy debt in its latest filings, and its share price is down about 34% over the past year.

Dawonsys makes specialized power supply equipment for nuclear fusion research, plasma processing, induction heating and urban rail. Its trailing twelve-month figures to H1 2026 show revenue of about ₩52.5B against an operating loss of about ₩114.7B, with borrowings of about ₩338.9B and negative free cash flow. Recent filings point to listing-related and audit-related notices, a trading halt and a loan extension.

What stands out

  • Revenue fell from ₩301.5B in 2024 to ₩112.1B in 2025, and the trailing twelve months to H1 2026 show ₩52.5B.
  • Operating losses widened sharply, from a ₩7.6B profit in 2024 to a ₩120.7B loss in 2025 and a ₩114.7B loss on a trailing basis.
  • Borrowings of about ₩338.9B far exceed cash of about ₩15.7B, and free cash flow over the trailing period was negative at about ₩132.2B.
  • The August 2026 half-year filing included an adverse audit opinion, a capital impairment notice, and a notice of a revenue shortfall, and filings from September include a trading halt and delisting-related items.
  • The share price closed at ₩2,530 with a market value of about ₩96.6B, and the 52-week range is ₩2,015 to ₩4,350; foreign ownership is about 5.2%, and the data shows no dividend.

What to watch

  • Whether the company resolves the listing-eligibility review and the trading halt, as referenced in the September filings.
  • The outcome of the loan period extension and whether the company can manage its borrowings against weak cash generation.
  • The next periodic filings for audit status and whether the revenue and equity shortfalls continue; the data does not include forecasts or analyst views.

Data as of Oct 30, 2026 · written 5h ago

This is not financial advice.

Also known as: Dawonsys / 다원시스 / 068240 / KRX:068240

Source: KRX statistical information